Free Trial

Fidelity Disruptive Medicine ETF (FMED) Short Interest Ratio & Short Volume

$25.95 +0.63 (+2.49%)
As of 03:54 PM Eastern

Fidelity Disruptive Medicine ETF Short Interest Data

Fidelity Disruptive Medicine ETF (FMED) has a short interest of 9,800 shares. This marks a -10.09% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.0, indicating that it would take 2.0 days of the average trading volume of 5,491 shares to cover all short positions.

Current Short Interest
9,800 shares
Previous Short Interest
10,900 shares
Change Vs. Previous Month
-10.09%
Dollar Volume Sold Short
$241,668.00
Short Interest Ratio
2.0 Days to Cover
Last Record Date
December 31, 2024
Outstanding Shares
2,100,000 shares
Percentage of Shares Shorted
0.47%
Today's Trading Volume
2,095 shares
Average Trading Volume
5,491 shares
Today's Volume Vs. Average
38%
Short Selling Fidelity Disruptive Medicine ETF?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Fidelity Disruptive Medicine ETF and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

FMED Short Interest Over Time

FMED Days to Cover Over Time

FMED Percentage of Float Shorted Over Time

Fidelity Disruptive Medicine ETF Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
12/31/20249,800 shares $241,668.00 -10.1%N/A2 $24.66
12/15/202410,900 shares $278,273.73 -67.5%N/A2.4 $25.53
11/30/202433,500 shares $879,073.50 +225.2%N/A6.8 $26.24
11/15/202410,300 shares $254,101.00 -19.5%N/A2.1 $24.67
10/31/202412,800 shares $326,784.00 +29.3%N/A2.5 $25.53
10/15/20249,900 shares $257,400.00 +50.0%N/A1.9 $26.00
9/30/20246,600 shares $173,514.00 -34.7%N/A1.3 $26.29
9/15/202410,100 shares $265,053.29 +71.2%N/A1.7 $26.24
8/31/20245,900 shares $153,511.51 -22.4%N/A0.9 $26.02
8/15/20247,600 shares $192,143.20 -33.3%N/A1.3 $25.28
7/31/202411,400 shares $281,580.00 +123.5%N/A1.9 $24.70
7/15/20245,100 shares $126,327.00 No ChangeN/A0.8 $24.77

FMED Short Interest - Frequently Asked Questions

What is Fidelity Disruptive Medicine ETF's current short interest?

Short interest is the volume of Fidelity Disruptive Medicine ETF shares that have been sold short but have not yet been closed out or covered. As of December 31st, traders have sold 9,800 shares of FMED short. Learn More on Fidelity Disruptive Medicine ETF's current short interest.

What is a good short interest ratio for Fidelity Disruptive Medicine ETF?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. FMED shares currently have a short interest ratio of 2.0. Learn More on Fidelity Disruptive Medicine ETF's short interest ratio.

Is Fidelity Disruptive Medicine ETF's short interest increasing or decreasing?

Fidelity Disruptive Medicine ETF saw a drop in short interest in the month of December. As of December 31st, there was short interest totaling 9,800 shares, a drop of 10.1% from the previous total of 10,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Fidelity Disruptive Medicine ETF's short interest compare to its competitors?

Here is how the short interest of companies compare to Fidelity Disruptive Medicine ETF: Tema Oncology ETF (0.31%), Fidelity Disruptive Communications ETF (2.05%), Spear Alpha ETF (1.86%), Procure Space ETF (0.63%), AOT Growth & Innovation ETF (0.02%), Global X Aging Population ETF (0.10%), Tradr 2X Long Innovation ETF (12.77%), Roundhill Daily 2X Long Magnificent Seven ETF (0.25%), Siren Nasdaq NexGen Economy ETF (0.26%), CrossingBridge Pre-Merger SPAC ETF (0.46%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.83 billion), Charter Communications, Inc. ($3.77 billion), Reddit, Inc. ($2.98 billion), The Kroger Co. ($2.97 billion), International Paper ($2.64 billion), SoFi Technologies, Inc. ($1.99 billion), Rivian Automotive, Inc. ($1.93 billion), Onsemi ($1.81 billion), SoundHound AI, Inc. ($1.59 billion), and Moderna, Inc. ($1.57 billion). View all of the most shorted stocks.

What does it mean to sell short Fidelity Disruptive Medicine ETF stock?

Short selling FMED is an investing strategy that aims to generate trading profit from Fidelity Disruptive Medicine ETF as its price is falling. FMED shares are trading up $0.55 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Fidelity Disruptive Medicine ETF?

A short squeeze for Fidelity Disruptive Medicine ETF occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of FMED, which in turn drives the price of the stock up even further.

How often is Fidelity Disruptive Medicine ETF's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FMED, twice per month. The most recent reporting period available is December, 31 2024.




This page (NASDAQ:FMED) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners